QC6352

12 Cited Publications
Customer Review

Based on 12 publication(s) in Google Scholar

QC6352 is a DHODH and KDM4 inhibitor. The IC50 values of QC6352 for human DHODH, KDM4A, KDM4B, KDM4C, and KDM4D are 0.3 nM, 104 nM, 56 nM, 35 nM, and 104 nM, respectively. QC6352 inhibits JmjC domain Fe (II)/2-ketoglutarate-dependent histone demethylases and blocks DHODH-mediated de novo pyrimidine biosynthesis through ubiquinone binding, reducing H3K9me3/H3K36me3 demethylation and increasing histone methylation marks. QC6352 induces G0/G1 phase arrest, senescence, apoptosis (apoptosis), DNA damage, and interferon/chemokine responses, and reduces stemness markers and BMI1+ cancer stem cells, exhibiting selective antiproliferative/cytotostatic activity against glioblastoma cells with limited effects on normal astrocytes. QC6352 can be used for research on glioblastoma, breast cancer, squamous cell carcinoma, and TP53-mutant acute myeloid leukemia.

For research use only. We do not sell to patients.

  • Purity : 99.13%
  • CAS No.: 1851373-36-8
  • Formula: C24H25N3O2
  • Molecular Weight:387.47
  • Storage:

    4°C, protect from light

    * In solvent : -80°C, 2 years; -20°C, 1 year (protect from light)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00